Factors associated with the administration of tissue plasminogen activator for acute ischemic stroke.

@article{Kunisawa2014FactorsAW,
  title={Factors associated with the administration of tissue plasminogen activator for acute ischemic stroke.},
  author={Susumu Kunisawa and Daisuke Kobayashi and Jason Z Lee and Tetsuya Otsubo and Hiroshi Ikai and Chiaki Yokota and Kazuo Minematsu and Yuichi Imanaka},
  journal={Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association},
  year={2014},
  volume={23 4},
  pages={724-31}
}
BACKGROUND The use of intravenous tissue plasminogen activator (t-PA) can be an effective treatment for acute ischemic stroke if administered promptly. Despite its clinical effectiveness, overall use in Japan remains low, and regional variations have been reported. Factors such as ambulance utilization and geographical distance from patients' residences to hospitals may influence t-PA administration rates. The aim of this study is to identify factors associated with the administration of t-PA… CONTINUE READING